Services
Market entry strategy
Before you invest in registration, we help you understand demand, competition and pricing for your products in Iraq, product by product.
Answers specific to your portfolio
General market reports rarely help with the decisions a manufacturer actually has to make. Our assessments are built around your therapeutic area, your products and your commercial targets.
Because we also register and distribute, our analysis draws on what we see every day in pharmacies, hospitals and committee rooms, not only on published figures.
The questions we answer
- How big is the market for this product?
- We estimate addressable demand for your therapeutic class using consumption data, public procurement history and prescribing patterns, separately for federal Iraq and the Kurdistan Region.
- Who are we up against?
- We map the products already on the market, including generics, how loyal prescribers are to them and where the gaps are that your product can fill.
- What price will the committee accept?
- The Ministry of Health applies strict CIF price caps. We model pricing scenarios against reference prices from neighbouring markets so your submission is competitive and still profitable.
- Which products should we register first?
- We recommend a sequence: which formulations to file first, whether to submit to the MOH and KMCA at the same time, and whether any product qualifies for a faster route as an essential medicine.